Literature DB >> 10400211

Soleus long-latency stretch reflexes during walking in healthy and spastic humans.

T Sinkjaer1, J B Andersen, J F Nielsen, H J Hansen.   

Abstract

The present study was carried out to investigate the long-latency soleus stretch reflexes M2 (peak latency of approximately 85 ms) and M3 (peak latency of approximately 115 ms) during walking in healthy and spastic multiple sclerosis (MS) patients. An 8 degrees stretch was applied to the ankle extensors of the left leg in 8 healthy subjects during normal walking speed and 9 spastic MS patients and 10 age-matched healthy subjects during slow walking. When present in walking healthy subjects, M2 and M3 were modulated in a similar way and with the same amplitudes as previously described for the short latency soleus stretch reflex (M1). The spastic patients' soleus M1 was significantly less modulated during walking. The patients' M2 long-latency response was modulated in the same way as the age-matched healthy subjects. All patients' M3 responses were absent or much suppressed during walking. The origin and functional importance of the short- and long-latency stretch reflexes in healthy and spastic persons are discussed in relation to the above findings and the behaviour of the stretch reflexes during matched isometric contractions. M3 is argued to be part of a transcortical reflex in healthy subjects.

Entities:  

Mesh:

Year:  1999        PMID: 10400211     DOI: 10.1016/s1388-2457(99)00034-6

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  28 in total

1.  Knee stabilization in patients with medial compartment knee osteoarthritis.

Authors:  Michael D Lewek; Dan K Ramsey; Lynn Snyder-Mackler; Katherine S Rudolph
Journal:  Arthritis Rheum       Date:  2005-09

2.  Four weeks of training in a sledge jump system improved the jump pattern to almost natural reactive jumps.

Authors:  Andreas Kramer; Ramona Ritzmann; Markus Gruber; Albert Gollhofer
Journal:  Eur J Appl Physiol       Date:  2011-05-05       Impact factor: 3.078

3.  Repetitive common peroneal nerve stimulation increases ankle dorsiflexor motor evoked potentials in incomplete spinal cord lesions.

Authors:  Aiko K Thompson; Brandon Lapallo; Michael Duffield; Briana M Abel; Ferne Pomerantz
Journal:  Exp Brain Res       Date:  2011-03-01       Impact factor: 1.972

Review 4.  Restoring walking after spinal cord injury: operant conditioning of spinal reflexes can help.

Authors:  Aiko K Thompson; Jonathan R Wolpaw
Journal:  Neuroscientist       Date:  2014-03-17       Impact factor: 7.519

5.  Evidence for a supraspinal contribution to the human quadriceps long-latency stretch reflex.

Authors:  N Mrachacz-Kersting; M J Grey; T Sinkjaer
Journal:  Exp Brain Res       Date:  2005-10-21       Impact factor: 1.972

6.  Major role for sensory feedback in soleus EMG activity in the stance phase of walking in man.

Authors:  T Sinkjaer; J B Andersen; M Ladouceur; L O Christensen; J B Nielsen
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

7.  Group II muscle afferents probably contribute to the medium latency soleus stretch reflex during walking in humans.

Authors:  M J Grey; M Ladouceur; J B Andersen; J B Nielsen; T Sinkjaer
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

8.  Medium-latency reflex response of soleus elicited by peroneal nerve stimulation.

Authors:  Hilmi Uysal; Lars-Erik Larsson; Hüsnü Efendi; David Burke; Cumhur Ertekin
Journal:  Exp Brain Res       Date:  2008-11-05       Impact factor: 1.972

9.  Movement strategies for maintaining standing balance during arm tracking in people with multiple sclerosis.

Authors:  Matthew C Chua; Allison S Hyngstrom; Alexander V Ng; Brian D Schmit
Journal:  J Neurophysiol       Date:  2014-06-25       Impact factor: 2.714

10.  Human stretch reflex pathways reexamined.

Authors:  S Utku Yavuz; Natalie Mrachacz-Kersting; Oguz Sebik; M Berna Ünver; Dario Farina; Kemal S Türker
Journal:  J Neurophysiol       Date:  2013-11-13       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.